Author:
Kern-Goldberger Andrew S.,Hill-Ricciuti Alexandra C.,Zhou Juyan J.,Savant Adrienne P.,Rugg Larissa,Dozor Allen J.,Welter John,Saiman Lisa,Quittell Lynne M.
Funder
Cystic Fibrosis Foundation
American Academy of Pediatrics
Subject
Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health
Reference31 articles.
1. The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases;Goss;Adv Drug Deliv Rev,2002
2. Opening doors to CF clinical research: change is coming (plenary session #2);Retsch-Bogart,2015
3. Breakthrough therapies: cystic fibrosis (CF) potentiators and correctors;Solomon;Pediatr Pulmonol,2015
4. Minorities are underrepresented in clinical trials of pharmaceutical agents for cystic fibrosis;McGarry;Ann Am Thorac Soc,2016
5. Understanding of safety monitoring in clinical trials by individuals with CF or their parents: a qualitative analysis;Kern-Goldberger;J Cyst Fibros,2018
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献